Day: July 25, 2025

The invention relates to a pharmaceutical composition of corticosteroid aqueous nasal spray solution and a method of preparation thereof that is safe and cost effective. The method of this patent involves relatively lesser number of steps and does not require MDRS studies, thus saving expenses on analysis and batch release tests. This patent provides an …

The invention relates to a dry powder inhalation (DPI) formulation and a process for its preparation. The dry powder inhalation formulation comprises micronized favipiravir/Ivermectin, first lactose, second lactose, and optionally at least one excipient. The dry powder formulation of this patent increases the bioavailability of the Favipiravir/Ivermectin, patient compliance, and reduced adverse effects. Patent Status: …